Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 53
Filtrar
1.
Balkan Med J ; 36(2): 88-95, 2019 02 28.
Artículo en Inglés | MEDLINE | ID: mdl-30322831

RESUMEN

Background: Postoperative complications occur after periodontal plastic surgeries, but an ideal treatment to overcome them has not been found yet. Aims: To evaluate the effects of topically applied Oral-norm gel on the healing of excisional wounds. Study Design: Animal experiment. Methods: Excisional wounds with a diameter of 3 mm were made in the center of the palatal mucosa of 63 Sprague Dawley rats. Seven animals were sacrificed at time 0. The remaining rats were divided into two groups: a test group in which the topical Oral-norm gel was applied three times a day and a control group in which nothing was applied. Seven animals in each group were sacrificed at 3, 7, 14, and 21 days. Mean wound surface area was measured photographically, while wound healing and width were evaluated microscopically. Results: The mean wound surface area decreased significantly after 3 days in both groups (p<0.001). Between days 3 and 7, the mean wound surface area decreased from 6.62 (2.85) to 0.83 (1.62) mm2 in the control group and 5.07 (0.88) to 1.42 (1.67) mm2 in the test group. The wound width decreased significantly on day 7 in both groups (p<0.001), with no further changes by day 14. Both groups had a significant increase in inflammation and vascularization on day 3 (p<0.001), with a reduction thereafter. No significant differences in macroscopic and microscopic measurements were observed between the groups at any time point (p>0.05). Conclusion: The Oral-norm gel has no positive healing effects in the palatal mucosa of rats.


Asunto(s)
Administración Tópica , Combinación de Medicamentos , Hueso Paladar/efectos de los fármacos , Cicatrización de Heridas , Animales , Modelos Animales de Enfermedad , Lidocaína/farmacología , Lidocaína/uso terapéutico , Hueso Paladar/lesiones , Ácido Pantoténico/análogos & derivados , Ácido Pantoténico/farmacología , Ácido Pantoténico/uso terapéutico , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Ratas , Ratas Sprague-Dawley/lesiones , Ácidos Undecilénicos/farmacología , Ácidos Undecilénicos/uso terapéutico
2.
J Burn Care Res ; 39(3): 413-422, 2018 04 20.
Artículo en Inglés | MEDLINE | ID: mdl-29897542

RESUMEN

An enzyme mixture containing bromelain (NexoBrid®) was found to be suitable for enzymatic debridement of burn wounds, as determined by the criteria of patient comfort and pain, selectivity, and efficiency. Nevertheless, daily experience showed that pretreatment of burn wounds with several other clinical agents may inhibit debridement efficiency. Therefore, the current study was performed to identify those agents and evaluate their debridement inhibition capabilities. The impact of several common agents as well pH, on NexoBrid® debridement efficiency was evaluated in vitro. A collagen-based dermal substitute (MatriDerm®) was exposed to NexoBrid® in the presence of different agents of varying concentrations. Digestion was documented. The criteria used for judging digestion were independently classified by 3 investigators at least 3 times in succession. When a low concentration (1.0 mg/ml) of NexoBrid® was used, a ≥ 50% concentration of Prontosan® had an impact on enzymatic activity. Comparable results were obtained when even lower concentrations of Octenisept® (≥ 10%) were used. A 100-µmol/L concentration of copper inhibited the enzymatic activity of both a low (1.0 mg/ml) and high (10 mg/ml) concentration of NexoBrid®. Silver-sulfadiazine at concentrations of 10% and 90% inhibited the activity of 1 mg/ml NexoBrid®. No complete inhibition of NexoBrid® activity occurred at any concentration of iron. We recommend using polyhexanide-containing agents (Prontosan®) to rinse and presoak burn wounds. Pretreatment of burn wounds with agents containing silver and copper should be avoided. Experimentally, we found a partial inhibition of NexoBrid® activity at the distinct pH values of 3 and 11.


Asunto(s)
Antiinfecciosos Locales/química , Bromelaínas/química , Quemaduras/terapia , Desbridamiento/métodos , Antiinfecciosos Locales/uso terapéutico , Betaína/análogos & derivados , Betaína/química , Betaína/uso terapéutico , Biguanidas/química , Biguanidas/uso terapéutico , Bromelaínas/uso terapéutico , Colágeno/química , Colágeno/uso terapéutico , Elastina/química , Elastina/uso terapéutico , Etanolaminas/química , Etanolaminas/uso terapéutico , Iminas , Piridinas/química , Piridinas/uso terapéutico , Piel Artificial , Ácidos Undecilénicos/química , Ácidos Undecilénicos/uso terapéutico
3.
Br J Nurs ; 15(22): 1222, 1224-8, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17346020

RESUMEN

Chronic wounds present a challenge that is costly in terms of quality of life to the patient and in financial terms for the NHS. Several factors contribute to the development of a chronic wound, in particular the influence of bacteria as a biofilm within the wound environment. Irrigating a wound with normal saline has long been advocated as the most appropriate method of wound irrigation but biofilms are now known to be resistant to this method of cleansing. A small (10 patient) evaluation of the use of Prontosan in patients whose duration of chronic wounds exceeded 1 year has demonstrated that Prontosan wound irrigation and Prontosan gel are an appropriate alternative for cleaning, moistening and decontaminating encrusted, contaminated and chronic skin wounds, and can have a dramatic influence of the quality of life for such patients. This article discusses the cause of chronicity within a wound and discusses in depth three of the ten patients in the evaluation.


Asunto(s)
Biguanidas/uso terapéutico , Cuidados de la Piel/métodos , Tensoactivos/uso terapéutico , Irrigación Terapéutica/métodos , Infección de Heridas/prevención & control , Administración Cutánea , Anciano , Anciano de 80 o más Años , Betaína/uso terapéutico , Biopelículas , Enfermedad Crónica , Combinación de Medicamentos , Femenino , Geles , Humanos , Control de Infecciones/métodos , Masculino , Calidad de Vida , Compuestos de Plata/uso terapéutico , Cuidados de la Piel/enfermería , Irrigación Terapéutica/enfermería , Resultado del Tratamiento , Ácidos Undecilénicos/uso terapéutico , Cicatrización de Heridas , Infección de Heridas/psicología
4.
J Med Chem ; 33(1): 430-4, 1990 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-2296033

RESUMEN

A series of 7 alpha-undecylestradiol derivatives, featuring various substituents at the end of the undecyl spacer chain, were synthesized and evaluated for their interaction with the estrogen receptor and nonreceptor sites. Their relative binding affinities (RBA) for calf uterine estrogen receptors were measured by competitive binding assays and varied between 0.5 and 8.4% of that of unlabeled 17 beta-estradiol. Enhanced lipophilicity and steric hindrance of the substituent on the end of the spacer chain resulted in decreased binding affinity for the estrogen receptor, while interactions with nonreceptor sites increased. RBA values were not affected by prolonged incubation times, suggesting a stable ligand-receptor complex. The potential to use the 7 alpha-undecylestradiol as a vector for site-selective delivery of diagnostic and therapeutic moieties to estrogen-receptor-positive human cancers is discussed.


Asunto(s)
Neoplasias de la Mama/análisis , Estradiol/análogos & derivados , Receptores de Estrógenos/metabolismo , Ácidos Undecilénicos/metabolismo , Animales , Unión Competitiva , Neoplasias de la Mama/tratamiento farmacológico , Bovinos , Fenómenos Químicos , Química , Estradiol/síntesis química , Estradiol/metabolismo , Estradiol/uso terapéutico , Femenino , Estructura Molecular , Receptores de Estrógenos/análisis , Relación Estructura-Actividad , Ácidos Undecilénicos/síntesis química , Ácidos Undecilénicos/uso terapéutico , Útero/metabolismo
5.
Antiviral Res ; 40(3): 139-44, 1999 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-10027648

RESUMEN

There is increasing interest in the use of topical microbicides to help prevent the spread of sexually transmitted diseases (STD). Undecylenic acid (UA), a monosaturated fatty acid, is the active ingredient in a number of over-the-counter (OTC) antifungal spray powders, that also exhibits in vitro antibacterial and antiviral activity, including herpes simplex virus (HSV) activity. We, therefore, evaluated UA as a topical microbicide against genital HSV infection using the murine and guinea pig models of genital herpes. Mice were administered a 20% solution of UA in polyethylene glycol (PEG) vehicle, vehicle alone or phosphate buffered saline (PBS) intravaginally immediately prior to vaginal challenge with HSV-2. Pre-treatment with UA decreased the number of mice that became infected (P < 0.001 vs. PBS or vehicle control), developed symptoms (P <0.001) or died (P <0.001). However, when treatment was extended to either 5 min prior to or after viral inoculation, protection was lost. Similar findings were found using the guinea pig model, where UA treatment completely prevented HSV-2 vaginal infection when given immediately prior to HSV-2 inoculation (P<0.001 vs. PBS or vehicle control). Thus, UA, an approved OTC medication, provided significant protection against HSV disease and infection only when applied immediately before viral inoculation, indicating that better formulations were needed to extend the duration of protection.


Asunto(s)
Antivirales/uso terapéutico , Herpes Genital/tratamiento farmacológico , Ácidos Undecilénicos/uso terapéutico , Administración Tópica , Animales , Antivirales/administración & dosificación , Modelos Animales de Enfermedad , Femenino , Cobayas , Herpes Genital/prevención & control , Ratones , Resultado del Tratamiento , Ácidos Undecilénicos/administración & dosificación , Vagina/virología
6.
Cutis ; 23(5): 696-8, 1979 May.
Artículo en Inglés | MEDLINE | ID: mdl-378561

RESUMEN

To evaluate the relative effectiveness of the treatment of tinea pedis, we performed a double-blind study comparing undecylenic acid ointment, tolnaftate cream, and a placebo. Ninety patients with clinically and mycologically proven tinea pedis took part in this clinical trial. Our results showed both agents to be superior to the placebo, but there was no significant difference in effectiveness between the two active agents. We observed no side effects with the preparations used.


Asunto(s)
Tiña del Pie/tratamiento farmacológico , Tolnaftato/uso terapéutico , Ácidos Undecilénicos/uso terapéutico , Ensayos Clínicos como Asunto , Método Doble Ciego , Humanos , Medicamentos sin Prescripción , Placebos
7.
Cutis ; 25(5): 544-6, 549, 1980 May.
Artículo en Inglés | MEDLINE | ID: mdl-6991217

RESUMEN

A double-blind parallel study comparing tolnaftate cream with undecylenic acid ointment and a placebo ointment in the treatment of symptomatic tinea pedis was conducted on the warm, humid Texas Gulf Coast. In one hundred and three patients studied, both the clinical and mycological effects of the two antifungal agents were indistinguishable. Both were significantly more effective than the placebo.


Asunto(s)
Tiña del Pie/tratamiento farmacológico , Tolnaftato/uso terapéutico , Ácidos Undecilénicos/uso terapéutico , Ensayos Clínicos como Asunto , Método Doble Ciego , Humanos , Masculino , Pomadas , Tiña del Pie/microbiología , Tolnaftato/administración & dosificación , Ácidos Undecilénicos/administración & dosificación
8.
Pediatr Ann ; 5(12): 800-11, 1976 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-136628

RESUMEN

Fungal infections of the skin in children are common and may mimic many other dermatoses. Diagnostic techniques are simple and inexpensive; Wood's light examination, KOH wet mounts, and preferably fungal culture should be performed on all suspected lesions.


Asunto(s)
Dermatomicosis/diagnóstico , Acetatos/uso terapéutico , Adolescente , Aluminio/uso terapéutico , Arthrodermataceae/aislamiento & purificación , Candida albicans/aislamiento & purificación , Candidiasis/diagnóstico , Candidiasis Bucal/diagnóstico , Preescolar , Humanos , Onicomicosis/diagnóstico , Permanganato de Potasio/uso terapéutico , Tiña del Cuero Cabelludo/diagnóstico , Tiña del Pie/diagnóstico , Tiña Versicolor/diagnóstico , Ácidos Undecilénicos/uso terapéutico
9.
Eur J Pharm Sci ; 46(1-2): 17-25, 2012 May 12.
Artículo en Inglés | MEDLINE | ID: mdl-22333440

RESUMEN

The key neuropathological features of Alzheimer's disease are abnormal deposition of Aß plaques and insoluble Aß peptides in extracellular brain and intracellular neurofibril tangles induced by abnormal tau hyperphosphorylation. µ-Calpain is one of the factors that bridge these Aß- and hyperphosphorylated tau-mediated pathological pathways. Undecylenic acid (UDA), a naturally occurring unsaturated fatty acid, was discovered as a µ-calpain inhibitor by screening a chemical library using a substrate specific µ-calpain assay method. UDA inhibited Aß oligomerization and Aß fibrillation and reversed Aß-induced neuronal cell death. In addition, UDA scavenged ROS and reversed the levels of proapoptotic proteins induced by ROS in SH-SY5Y cells. UDA inhibited µ-calpain activity with better potency than the known peptide-like µ-calpain inhibitor, MDL28170, in SH-SY5Y and HEK293T cells transfected with the catalytic subunit of µ-calpain. These results suggest that UDA is a novel non-peptide-like µ-calpain inhibitor with good cell permeability and potent neuroprotective effect.


Asunto(s)
Péptidos beta-Amiloides/antagonistas & inhibidores , Calpaína/antagonistas & inhibidores , Supervivencia Celular/efectos de los fármacos , Fármacos Neuroprotectores/farmacología , Ácidos Undecilénicos/farmacología , Enfermedad de Alzheimer/tratamiento farmacológico , Muerte Celular/efectos de los fármacos , Línea Celular Tumoral , Interpretación Estadística de Datos , Dipéptidos/farmacología , Descubrimiento de Drogas , Células HEK293 , Humanos , Microscopía de Fuerza Atómica , Neuronas/efectos de los fármacos , Neuronas/enzimología , Fármacos Neuroprotectores/uso terapéutico , Permeabilidad/efectos de los fármacos , Placa Amiloide/tratamiento farmacológico , Especies Reactivas de Oxígeno/antagonistas & inhibidores , Ricinus/química , Bibliotecas de Moléculas Pequeñas , Ácidos Undecilénicos/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA